老挝全球药房Laos Global Pharmacy
Carrying forward a five-thousand-year legacy, safeguarding modern health
艾拉司群是全球首个获批的口服选择性雌激素受体降解剂(SERD),专为ER阳性、HER2阴性、携带ESR1活化突变的晚期乳腺癌患者设计。
所有称呼艾拉司群、Elacestrant、Orserdu、LuciElace
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH
Order on WhatsApp